Research Analysts’ Weekly Ratings Changes for Milestone Scientific (MLSS)

Milestone Scientific (NYSE: MLSS) has recently received a number of price target changes and ratings updates:

• 11/26/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 11/20/2024 – Milestone Scientific had its “speculative buy” rating reaffirmed by analysts at Benchmark Co.. They now have a $1.25 price target on the stock.
• 11/18/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 11/10/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 11/2/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 10/25/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 10/17/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 10/10/2024 – Milestone Scientific is now covered by analysts at Benchmark Co.. They set a “speculative buy” rating and a $1.25 price target on the stock.
• 10/9/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 10/1/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.

Milestone Scientific Stock Performance

MLSS traded up $0.02 on Wednesday, reaching $1.02. The company had a trading volume of 409,352 shares, compared to its average volume of 114,157. Milestone Scientific Inc. has a fifty-two week low of $0.52 and a fifty-two week high of $1.10. The stock has a market cap of $79.40 million, a P/E ratio of -14.56 and a beta of 1.08. The company’s fifty day moving average is $0.83 and its 200 day moving average is $0.84.

Insiders Place Their Bets

In related news, Director Leonard Osser sold 107,984 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the completion of the transaction, the director now owns 4,606,882 shares of the company’s stock, valued at $4,284,400.26. This represents a 2.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders have sold a total of 109,193 shares of company stock worth $101,634 in the last quarter. Corporate insiders own 24.75% of the company’s stock.

Hedge Funds Weigh In On Milestone Scientific

Several institutional investors and hedge funds have recently added to or reduced their stakes in MLSS. Y Intercept Hong Kong Ltd bought a new position in shares of Milestone Scientific during the third quarter valued at $48,000. World Investment Advisors LLC bought a new position in shares of Milestone Scientific during the third quarter valued at $91,000. Finally, Geode Capital Management LLC raised its stake in shares of Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after acquiring an additional 31,572 shares during the last quarter. Institutional investors own 5.79% of the company’s stock.

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.